Physician profile
Andrew Kelts
NPI 1669890448
$3,626.96
in general payments reported to CMS, 2019-2025
17 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $851 · 2020: $502 · 2021: $362 · 2022: $753 · 2023: $353 · 2024: $527 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $934.94 | 2019-2025 | |
| Boston Scientific Corporation | $837.76 | 2021-2024 | |
| Endogastric Solutions, INC | $317.07 | 2022-2024 | Esophyx |
| Takeda Pharmaceuticals U.S.A., INC. | $253.23 | 2021-2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $203.16 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $169.82 | 2019-2020 | |
| Madrigal Pharmaceuticals | $145.29 | 2024 | Rezdiffra |
| Fujifilm Healthcare Americas Corporation | $144.76 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2025 | Farxiga |
| Janssen Biotech, INC. | $122.37 | 2019-2025 | Tremfya |
| Steris Corporation | $107.50 | 2022 | |
| Janssen Scientific Affairs, LLC | $82.18 | 2019 | |
| Gilead Sciences, INC. | $71.34 | 2020 | |
| Medtronic, INC. | $42.25 | 2024 | Synchromedii |
| Mauna Kea Technologies, INC. | $30.92 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $20.62 | 2019 | |
| Concordia Pharmaceuticals INC. | $18.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kelts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.